A new study found that fair prices for medications like Wegovy and Zepbound would be hundreds less per month than they are ...

Several weight loss drug stocks are sliding today as pharmaceutical companies battle for dominance in the booming GLP-1 ...

Roche moved to enter the booming weight-loss drug market now dominated by Novo Nordisk and Eli Lilly. The Swiss ...

Why some health groups are banding together to push for a range of obesity-care options in workplace-sponsored insurance.

How weight loss drugs actually work, and how big-name prescriptions differ from each other. What investors need to know about ...

It's not too often that pharmaceutical drugs become household names, but that's happening with medicines in the weight loss ...

Compounded versions of popular drugs used for weight loss including Wegovy and Zepbound will soon no longer be available ...

Consumers who use telehealth or medical spas to get less expensive, compounded weight loss drugs will need to get their ...

Telemedicine operator Teladoc Health Inc (NYSE:TDOC) has entered a pharmacy integration agreement with Eli Lilly And Co's ...

After Zepbound-maker Eli Lilly reduced the price of the weight-loss drug, competitor Novo Nordisk has cut the price of weight ...

To be a person in the year 2025 is to encounter, in one way or another, the marketing onslaught for compounded ...

Weight loss drugs like tirzepatide and semaglutide are growing in popularity and offer significant health benefits, but they ...